Markham Drew G 4

4 · MICROVISION, INC. · Filed Jun 6, 2025

Form 4

Period: 2025-06-04

Transactions

Tax Payment
Common Stock
2025-06-05$1.12/sh−69,140$77,644→ 378,934 total
Exercise/Conversion
Restricted Stock Units
2025-06-04−139,688→ 0 total
Exercise: $0.00From: 2025-06-04Exp: 2025-06-04→ Common stock (139,688 underlying)
Award
Restricted Stock Units
2025-06-06+360,000→ 0 total
Exercise: $0.00From: 2026-06-06Exp: 2028-06-06→ Common stock (360,000 underlying)
Exercise/Conversion
Common Stock
2025-06-04+139,688→ 328,194 total
Exercise/Conversion
Common Stock
2025-06-04+119,880→ 448,074 total
Award
Restricted Stock Units
2025-06-04+139,688→ 139,688 total
Exercise: $0.00From: 2025-06-04Exp: 2025-06-04→ Common stock (139,688 underlying)
Exercise/Conversion
Restricted Stock Units
2025-06-04−119,880→ 0 total
Exercise: $0.00From: 2025-06-04Exp: 2025-06-04→ Common stock (119,880 underlying)

Footnotes (8)

[F1]Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
[F2]Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement.
[F3]Represents execution price.
[F4]Each RSU represents a contingent right to receive one share of MicroVision common stock.
[F5]RSUs vested on June 4, 2025, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2025 Executive Bonus Plan.
[F6]At vesting, converts into shares of common stock on a unit-for-share basis.
[F7]On June 4, 2024, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on June 4, 2027, subject to the Reporting Person's continued employment with the Issuer on each vesting date.
[F8]On June 6, 2025, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on June 6, 2028, subject to the Reporting Person's continued employment with the Issuer on each vesting date.

Documents

1 file